Externally accessible replaceable power source von Singer, James H, Mayes, Bradley E, Norton, John, Allen, Joseph R

Volltext bestellen

EXTERNALLY ACCESSIBLE REPLACEABLE POWER SOURCE von Singer James H, Mayes Bradley E, Allen Joseph R, Norton John

Volltext bestellen

EXTERNALLY ACCESSIBLE REPLACEABLE POWER SOURCE von ALLEN, Joseph R, SINGER, James H, NORTON, John, MAYES, Bradley E

Volltext bestellen

Externally accessible replaceable power source von SINGER, JAMES H, MAYES, BRADLEY E, NORTON, JOHN, ALLEN, JOSEPH R

Volltext bestellen

Development of improved higher-order correction for the NIF opacity spectrometer von Hobbs, B. A., Mayes, D. C., Heeter, R. F., Bradley, P. A., Dutra, E. C., Fontes, C. J., Gallardo-Diaz, E., Hohenberger, M., Johns, H. M., Opachich, Y. P., Robey, H. F., Stoupin, S., Wallace, M. S., Webster, L. G., Montgomery, M. H., Perry, T. S., Winget, D. E.

Volltext

Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis von Spiera, Robert, Kuwana, Masataka, Khanna, Dinesh, Hummers, Laura, Frech, Tracy M., Stevens, Wendy, Matucci‐Cerinic, Marco, Kafaja, Suzanne, Distler, Oliver, Jun, Jae‐Bum, Levy, Yair, Leszcyzński, Piotr, Gordon, Jessica, Steen, Virginia, Lee, Eun Bong, Jankowski, Tomasz, Litinsky, Irena, Chung, Lorina, Hsu, Vivien, Mayes, Maureen, Sandorfi, Nora, Simms, Robert W., Finzel, Stephanie, Vries‐Bouwstra, Jeska, Constantine, Scott, Dgetluck, Nancy, Dinh, Quinn, Bloom, Bradley J., Furst, Daniel E., White, Barbara, Denton, Christopher P., Kavanaugh, Arthur, Furst, Daniel E., Kafaja, Suzanne, Chung, Lorinda, Fischer, Aryeh, Steen, Virginia, Varga, John, Saketkoo, Lesley, Hummers, Laura, Castelino, Flavia V., Simms, Robert, Nagaraja, Vivek, Molitor, Jerry, Orzechowski, Nicole M., Hsu, Vivien M., Bernstein, Elana J., Spiera, Robert, Gordon, Jessica, Chatterjee, Soumya, Kahaleh, Bashar, Sandorfi, Nora, Domsic, Robyn T., Smith, Edwin, Kurepa, Zoran, Mayes, Maureen, Frech, Tracy, Csuka, Mary Ellen, Proudman, Susanna, Thakkar, Vivek, Stevens, Wendy, Youssef, Peter, Baron, Murray, Robinson, David, Kedor, Claudia, Distler, Jörg, Finzel, Stephanie, Moinzadeh, Pia, König, Ramona, Pfeiffer, Christiane, Blank, Norbert, Balbir‐Gurman, Alexandra, Rosner, Itzhak, Levy, Yair, Lidar, Merav, Lee, Eun Bong, Lee, Chang Keun, Jun, Jae‐Bum, Ju, Ji Hyeon, Dalm, V.A.S.H., Schouffoer, Anne A., Vries‐Bouwstra, Jeska Kirsten, Krasowska, Dorota, Leszczynsk, Piotr, Kowalewska, Bozena, Barranco, Ivan Castellvi, Sancho, Juan Jose Alegre, Rubbert‐Roth, Andrea, Distler, Oliver, Del Galdo, Francesco, Denton, Christopher C., D'Cruz, David, Herrick, Ariane, Baines, Colin, Griffiths, Bridget, Douglas, Karen

Volltext

Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis von Spiera, Robert, Kuwana, Masataka, Khanna, Dinesh, Hummers, Laura, Frech, Tracy M, Stevens, Wendy, Matucci-Cerinic, Marco, Kafaja, Suzanne, Distler, Oliver, Jun, Jae-Bum, Levy, Yair, Leszcyzński, Piotr, Gordon, Jessica, Steen, Virginia, Lee, Eun Bong, Jankowski, Tomasz, Litinsky, Irena, Chung, Lorina, Hsu, Vivien, Mayes, Maureen, Sandorfi, Nora, Simms, Robert W, Finzel, Stephanie, de Vries-Bouwstra, Jeska, Constantine, Scott, Dgetluck, Nancy, Dinh, Quinn, Bloom, Bradley J, Furst, Daniel E, White, Barbara

Volltext

Pharmaceutical development of IPI-504, an Hsp90 inhibitor and clinical candidate for the treatment of cancer von Porter, James R., Adams, Julian, Ahn, Rebecca, Ammoscato, Vince, Arsenault, Brendan, Austad, Brian C., Baker, Gary, Basuki, Johan, Booth, Marlene R., Campbell, Matthew J., Carter, Bennett, Curtis, Michael, Depew, Kris, Douglas, Mark A., Ge, Jie, Grenier, Louis, Helble, Joseph, Henderson, John, Goltz, Natalie, Ionescu, Dumitru, Kott, Laila, Kropp, Jason T., Lee, John, Li, Kaiming, Maurer, Bradley, Mayes, Denise, Pak, Roger H., Piotrowski, Jason, Porter, Jennifer R., Rusch, David, Sylvester, Geoff E., Wong, Steven, Wright, Jim

Volltext

Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis von Spiera, Robert, Kuwana, Masataka, Khanna, Dinesh, Hummers, Laura, Frech, Tracy M, Stevens, Wendy, Matucci-Cerinic, Marco, Kafaja, Suzanne, Distler, Oliver, Jun, Jae-Bum, Levy, Yair, Leszcyzński, Piotr, Gordon, Jessica, Steen, Virginia, Lee, Eun Bong, Jankowski, Tomasz, Litinsky, Irena, Chung, Lorina, Hsu, Vivien, Mayes, Maureen, Sandorfi, Nora, Simms, Robert W, Finzel, Stephanie, de Vries-Bouwstra, Jeska, Constantine, Scott, Dgetluck, Nancy, Dinh, Quinn, Bloom, Bradley J, Furst, Daniel E, White, Barbara, Denton, Christopher P, RESOLVE-1 Study Group

Volltext bestellen

COMBINATIONS COMPRISING METAP2 INHIBITORS FOR THE TREATMENT OF CANCER von CORNELIUS Peter, SHANAHAN James, CARVER Bradley, J, MAYES Benjamin

Volltext bestellen